Measles Cases U.S. April 30: Market Hits Near-Certainty

The U.S. measles outbreak just repriced by 43 points in a single day. That kind of move does not happen on speculation. Something in the case count data landed hard enough to push this contract from a coin flip to near-certainty overnight, and the market is now treating 1,800 confirmed U.S. cases by April 30 as close to done.

The contract tracking measles cases in the U.S. by April 30 sits at 92.5% YES on Polymarket as of April 1, 2026. YES shares price at $0.93, NO shares at $0.08. The market has traded $66,415 in total volume, with $20,381 changing hands in the last 24 hours alone.

How the CDC Measles Threshold Contract Works

This contract resolves YES if confirmed U.S. measles cases reach 1,800 by April 30, 2026. Resolution follows publicly reported CDC case count data. It resolves NO if the count stays below that threshold when the clock runs out.

• YES: U.S. measles cases hit or exceed 1,800 by April 30, 2026. Price: $0.93. Probability: 92.5%. Resolves: April 30, 2026.
• NO: Cases remain below 1,800 through April 30, 2026. Price: $0.08. Probability: 7.5%. Resolves: April 30, 2026.

A NO buyer needs the outbreak to stall hard inside 29 days. That means either a rapid public health intervention containing new transmission clusters, a significant reporting delay pushing confirmed numbers below threshold at cutoff, or a methodological change in how CDC counts cases. None of those scenarios are impossible. The data just makes all of them look unlikely right now.

Sponsored Partner

Momentum and Market Signals

The 1-hour and 24-hour momentum read as one signal here: this contract moved 43 points on March 31 and has not pulled back. The trend score reflects a market that priced in new case count data and held. That kind of sustained move, without reversion, tells you traders are not second-guessing the catalyst.

Total volume stands at $66,415, with $27,954 in available liquidity. That is thin by prediction market standards. Volume below $1M means a single large position can move this price sharply in either direction. One big NO bet or a surprising CDC update could swing the contract several points before liquidity absorbs it. The 92.5% reading carries conviction, but the volume caveat is real.

KEY FACTORS

• 24-hour price change: Plus 43.0% on March 31, the contract’s largest single-day move. This tracks a new CDC case count update as the most likely driver.
• 7-day price change: Also plus 43.0%, meaning the entire price gain this week compressed into one day. No gradual drift. One data event repriced everything.
• Related market: Measles cases in U.S. in 2026 prices at 100% on Polymarket. The full-year market already treats a major 2026 outbreak as resolved. The April 30 threshold market is pricing whether the pace holds through month-end.
• Related market: CDC Level 3 Travel Warning by December 31 prices at 45%. That market sitting near a coin flip suggests traders see real but not certain escalation beyond current outbreak boundaries.
• Liquidity: $27,954 available. Below $1M threshold. New CDC weekly surveillance data or a state health department update could move price sharply before the April 30 close.

Lines Analysis: CDC Data Versus the Calendar

The case for YES is essentially the trajectory. A 43-point repricing in one session means case count data crossed a threshold that made 1,800 by April 30 look structurally probable, not just possible. The companion market pricing the full 2026 outbreak at 100% confirms traders already see the outbreak as historically significant. The only question left is whether confirmed cases clear 1,800 before April 30 or spill past the cutoff date.

The case for NO is narrow but not zero. CDC confirmed case counts depend on state-level reporting pipelines that can lag real-time transmission by one to two weeks. If a material share of cases currently in the reporting pipeline do not get officially confirmed before April 30, the contract could technically resolve NO even if the underlying outbreak exceeds the threshold. That is a procedural risk, not an epidemiological one. At 7.5%, the market is pricing exactly that kind of tail scenario.

SIGNALS TO MONITOR

• CDC weekly measles surveillance report: Published each week, typically mid-week. Any update pushing confirmed cases close to or above 1,800 before April 30 resolves this contract YES. Watch CDC’s Morbidity and Mortality Weekly Report.
• State health department updates: Large outbreak states like Texas, Ohio, and Florida report cases before CDC rolls them into national totals. State-level announcements can front-run the official CDC count.
• CDC Level 3 Travel Warning market at 45%: A move higher in that contract signals outbreak expansion and would likely push additional YES volume into this market.
• Reporting pipeline delays: If CDC’s next weekly report shows a smaller-than-expected confirmed case increase, it could briefly compress YES price, creating a short entry point for NO buyers betting on a cutoff-date timing miss.
• School district or religious community cluster announcements: Concentrated outbreaks in undervaccinated populations have driven most 2026 case growth. New cluster reports are the most direct accelerant for case count velocity.

The $66,415 in total volume is thin, but the directional conviction is clear. Buyers pushed this contract to 92.5% and held it there through a full day of trading after the March 31 catalyst. The data favors YES. The only credible NO scenario runs through reporting mechanics, not epidemiology. Here is what the measurements are telling us: the outbreak pace already in the data makes 1,800 cases by April 30 the base case, not the upside.

LINES VERDICT

YES: Outbreak Trajectory Supports Threshold by Month-End

The case count trajectory repriced this contract 43 points in one session and held. The data does not care about the politics, and right now it points directly at 1,800 confirmed cases before April 30.

What the market says: At 92.5%, traders treat this as near-certain. The thin liquidity means any sharp new data release before April 30 could move price quickly in either direction.

Key unknown: CDC’s next weekly surveillance report is the single most important data point. A confirmed case total already approaching 1,800 would effectively close this market early. A reporting delay showing slower official confirmation than expected is the one catalyst that could compress the YES price before resolution.